Loading…
Pulse Biosciences, Inc. is projected to rise to $39.26 by 2027, a +49% move from its current price of $26.29. PLSE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $25.43 | $26.31 | $27.23 | +0.09% |
| Jul 14 | $25.09 | $26.33 | $27.64 | +0.17% |
| Jul 15 | $24.84 | $26.36 | $27.97 | +0.26% |
| Jul 16 | $24.64 | $26.38 | $28.25 | +0.34% |
| Jul 17 | $24.46 | $26.40 | $28.50 | +0.43% |
| Jul 18 | $24.30 | $26.43 | $28.74 | +0.51% |
| Jul 19 | $24.16 | $26.45 | $28.95 | +0.60% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.16 | $26.45 | $28.95 | +0.60% |
| Week 2 | $23.41 | $26.61 | $30.24 | +1.20% |
| Week 3 | $22.88 | $26.77 | $31.31 | +1.81% |
| Week 4 | $22.47 | $26.93 | $32.27 | +2.42% |
| Week 5 | $22.12 | $27.09 | $33.17 | +3.04% |
| Week 6 | $21.83 | $27.25 | $34.02 | +3.65% |
| Week 7 | $21.58 | $27.41 | $34.83 | +4.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians.
The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Pulse Biosciences, Inc. (PLSE) is listed with a current price of $27.51 and a market capitalization of $1.9B. It ranks 2073 by market presence. The near-term outlook shows a trajectory toward higher prices, with the average price rising over the coming years and sizable upside opportunities across the forecast horizon.
A major floor 31.7% below — a decisive break under it would weaken the trend.
The nearest floor, 7.6% below — buyers have tended to step in here.
The nearest ceiling, 11.2% above — a clean break opens room to run.
A major ceiling 20.1% above — clearing it would confirm fresh momentum.
Key PLSE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLSE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.76 | Sell | $27.40 | Sell |
| MA 10 | $28.17 | Sell | $27.55 | Sell |
| MA 20 | $26.99 | Sell | $27.06 | Sell |
| MA 50 | $24.94 | Buy | $25.39 | Buy |
| MA 100 | $23.02 | Buy | $23.26 | Buy |
| MA 200 | $19.44 | Buy | $20.86 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.33 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -35.94 | Neutral |
| Williams %R (14) | -81.04 | Info |
| MACD (12,26,9) | -0.18 | Sell |
| ROC (12) | 1.31 | Buy |
| Bollinger %B (20,2) | 0.38 | Neutral |
| Stochastic %K (14) | 18.96 | Buy |
| TRIX (15) | 0.54 | Buy |
| Awesome (5,34) | 1.47 | Buy |
| Ultimate (7,14,28) | 42.28 | Neutral |
| Momentum (10) | -1.21 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 27.08 | Sell |
| ADX (14) | 14.06 | Neutral |
| ATR (14) | 0.83 | Info |
The near-term picture carries a BULLISH sentiment with an RSI of 60. The stock is trading above both the SMA50 at $23.85 and the SMA200 at $18.84, suggesting constructive momentum.
Key support is identified at $23.96 and resistance at $27.50, framing a modest trading range near the current level. The thirty-day price range spans from $21.11 to $35.84, indicating space for upside and some downside risk over the coming weeks.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.39 | $26.29 | $36.99 | 0% | Neutral | |
| $30.52 | $39.26 | $53.85 | +49% | Bullish | |
| $37.89 | $50.51 | $72.45 | +92% | Bullish | |
| $42.72 | $58.70 | $87.16 | +123% | Bullish | |
| $45.70 | $64.48 | $98.58 | +145% | Bullish | |
| $43.89 | $63.47 | $99.52 | +141% | Bullish | |
| $51.51 | $76.22 | $122.23 | +190% | Bullish | |
| $64.89 | $98.11 | $160.57 | +273% | Bullish | |
| $71.67 | $110.61 | $184.45 | +321% | Bullish | |
| $81.45 | $128.23 | $217.56 | +388% | Bullish | |
| $120.30 | $207.50 | $378.36 | +689% | Bullish | |
| $179.88 | $365.16 | $738.58 | +12.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $13.39 | $26.29 | $31.54 | +0.00% |
| August 2026 | $23.25 | $27.63 | $33.85 | +5.10% |
| September 2026 | $23.71 | $28.42 | $35.30 | +2.86% |
| October 2026 | $22.87 | $27.62 | $34.71 | -2.80% |
| November 2026 | $22.78 | $27.69 | $35.13 | +0.25% |
| December 2026 | $23.63 | $28.90 | $36.99 | +4.38% |
Click any year to see its month-by-month PLSE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PLSE is projected to trade between $13.39 and $36.99, averaging $26.29 — a potential gain of 0% from today's $26.29. A consolidation phase looks the most probable path here.
Pulse Biosciences, Inc.'s 2027 outlook centres on $39.26, within a $30.52 to $53.85 range. That is up +49% on the projected 2026 average. That marks a +49% change versus current levels. Momentum favours further upside here.
By 2028, PLSE could reach as high as $72.45, with a base case around $50.51 and support toward $37.89 — roughly +92% from $26.29. Buyers look set to stay in control over this stretch.
Expect PLSE to range from $42.72 to $87.16 through 2029. The $58.70 average target implies a +123% move from current prices. That is up +16% on the projected 2028 average. Momentum favours further upside here.
The PLSE price prediction for 2030 points to an average of $64.48 (low $45.70, high $98.58) — a potential gain of +145% on today's $26.29. Buyers look set to stay in control over this stretch.
In 2031, PLSE is projected to trade between $43.89 and $99.52, averaging $63.47 — a potential gain of +141% from today's $26.29. That is -2% versus the projected 2030 average. Momentum favours further upside here.
Pulse Biosciences, Inc.'s 2032 outlook centres on $76.22, within a $51.51 to $122.23 range. That is up +20% on the projected 2031 average. That marks a +190% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PLSE could reach as high as $160.57, with a base case around $98.11 and support toward $64.89 — roughly +273% from $26.29. Momentum favours further upside here.
Expect PLSE to range from $71.67 to $184.45 through 2034. The $110.61 average target implies a +321% move from current prices. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PLSE price prediction for 2035 points to an average of $128.23 (low $81.45, high $217.56) — a potential gain of +388% on today's $26.29. Momentum favours further upside here.
In 2040, PLSE is projected to trade between $120.30 and $378.36, averaging $207.50 — a potential gain of +689% from today's $26.29. That is up +62% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Pulse Biosciences, Inc.'s 2050 outlook centres on $365.16, within a $179.88 to $738.58 range. That is up +76% on the projected 2040 average. That marks a +12.9x change versus current levels. Momentum favours further upside here.
Investing $1,000 in PLSE today (≈ 38.037277 PLSE) could be worth
$13,889.6
+$12,889.6 (+1289%) by 2050 · US Dollar
Based on the average projected PLSE price of $365.16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLSEwould be worth at today's price.
$1,000 invested in PLSE on Jul 10, 2025 (≈ 58.411212 PLSE) would be worth
$1,535.63
+$535.63 (+53.6%) today · 1.54× · US Dollar
Based on a PLSE entry price of $17.12 vs. today's $26.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $29.2 | $900.19 | -10.0% |
| 1 month ago | $24.99 | $1,052.02 | +5.2% |
| 3 months ago | $18.67 | $1,408.14 | +40.8% |
| 6 months ago | $14.57 | $1,804.39 | +80.4% |
| 1 year ago | $17.12 | $1,535.63 | +53.6% |
| All time (5.0y) ago | $18.47 | $1,423.39 | +42.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLSE forecast.
Our base-case forecast reaches $53.00 around 2029.
Implied market cap at $53.00: $3.67B
The multi-year forecast tracks a rising price pathway with expanding upside. In 2026, the avg is $27.51 with ROI 0% and sentiment NEUTRAL. The next years show continued upside: 2027 avg $40.43, ROI 47%, sentiment BULLISH; 2028 avg $54.70, ROI 98.9%, sentiment BULLISH; 2029 avg $60.51, ROI 120%, sentiment BULLISH; 2030 avg $63.54, ROI 131%, sentiment BULLISH.
Further out, 2031 avg $63.92, ROI 132.4%, sentiment BULLISH; 2032 avg $74.50, ROI 170.9%, sentiment BULLISH; 2033 avg $95.45, ROI 247%, sentiment BULLISH; 2034 avg $110.21, ROI 300.7%, sentiment BULLISH; 2035 avg $125.41, ROI 356%, sentiment BULLISH.
The horizon extends to 2040 with avg $202.46 and ROI 636.1%, sentiment BULLISH; and to 2050 with avg $324.77 and ROI 1080.8%, sentiment BULLISH. These are estimates and not guarantees, and actual results will depend on market dynamics and company performance.
Tap a question to reveal the answer.
The forecast for 2030 shows an avg of $63.54, with a min of $43.19 and a max of $101.33; ROI is 131% and sentiment is BULLISH.
The disclosed forecasts show a path of rising averages and ROIs across years, including 2027 avg $40.43 (ROI 47%), 2028 avg $54.70 (ROI 98.9%), and 2050 avg $324.77 (ROI 1080.8%), with sentiment generally BULLISH after 2026.
Yes. The forecast shows a max of $101.33 in 2030, with higher max values later such as $125.33 in 2032 and $164.26 in 2033.
Current price is $27.51 and market cap is $1.9B.
The near-term outlook is BULLISH with RSI 60. 30-day range is $21.11 to $35.84; support is $23.96 and resistance is $27.50; SMA50 is $23.85 and SMA200 is $18.84.
Pulse Biosciences, Inc. Community Discussion
0Share your Pulse Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.